Atlas Trials

Two Dose Schedules of Panitumumab in Subjects With Advanced Solid Tumors

Clinical trial NCT00091806 · COMPLETED

Trial details

NCT number
NCT00091806
Sponsor
Amgen
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
TumorsOncologySolid Tumors
Start date
2004-08-01
Primary completion
2006-04-01
Enrollment
86

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.